Medical News Ireland  
Tue, 17th May 2022
Log In Medical News Ireland
Medical News Ireland
Medical News Ireland

Related Sites

medical news ireland medical news ireland medical news ireland


Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.

  • receive the eCopy two days prior to the printed edition.
  • can partake in our online MCQs.
  • can enter our online sports quiz.


Medicalindependent.ie is Ireland's only investigative medical news website for doctors, healthcare professionals and anyone with an interest in health issues.

Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.

Address: Top Floor, 111 Rathmines Road Lr, Dublin 6

Tel: 353 (01) 441 0024

GreenCross Publishing is owned by Graham Cooke.

You are reading 1 of 2 free-access articles allowed for 30 days

RCSI University of Medicine and Health Sciences

By Mindo - 02nd Nov 2020 | 57 views

Clinician researchers at RCSI University of Medicine and Health Sciences have developed, for the first time, a score that can accurately predict which patients will develop a severe form of COVID-19. The study was published in The Lancet's translational research journal EBioMedicine this month. The measurement, called the Dublin-Boston score, is designed to enable clinicians to make more informed decisions when identifying patients who may benefit from therapies, such as steroids, and admission to intensive care units. Pictured (l-r) is RCSI Professor of Medicine Gerry McElvaney, the study’s senior author with co-author, RCSI Professor of Anaesthesia and Critical Care, Ger Curley. Picture credit: Ray Lohan/ RCSI

Clinician researchers at RCSI University of Medicine and Health Sciences have developed, for the first time, a score that can accurately predict which patients will develop a severe form of Covid-19. The study was published in The Lancet’s translational research journal EBioMedicine last month. The measurement, called the Dublin-Boston score, is designed to enable clinicians to make more informed decisions when identifying patients who may benefit from therapies, such as steroids, and admission to intensive care units.

Pictured L-R are: RCSI Professor of Medicine Gerry McElvaney, the study’s senior author, with co-author, RCSI Professor of Anaesthesia and Critical Care Ger Curley

Leave a Reply

Latest
Latest Issue
View All
medical news
The Medical Independent 19th May 2022

You need to be logged in to access this content. Please login or sign up using the links below.

Login
Sign Up
Most Read
Read More